373
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

A retrospective review of on-admission factors on attainment of therapeutic serum concentrations of magnesium sulfate in women treated for a diagnosis of preeclampsia

, ORCID Icon, , , & ORCID Icon
Pages 258-266 | Received 05 Feb 2018, Accepted 12 Jun 2018, Published online: 17 Jul 2018

References

  • The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the collaborative Eclampsia Trial. Lancet. 1995;345(8963):1455–1463.
  • Altman D, Carroli G, Duley L, et al. Do women with preeclampsia, and their babies benefit from magnesium sulfate? The magpie Trial: a randomized placebo-controlled trial. Lancet. 2002;359(9321):1877–1890.
  • Cunningham FG, Leveno KL, Bloom SL, et al. Pregnancy hypertension: hypertensive disorders of pregnancy. 23rd ed. New York, (NY): McGrawHill; 2010.
  • Zuspan FP. Treatment of severe preeclampsia and eclampsia. Clin Obstet Gynaecol. 1966;9(4):954–972.
  • Sibai BM, Lipshitz J, Anderson GD, et al. Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia. Obstet Gynecol. 1981;57(2):199–202.
  • Magpie Trial Follow-Up. The magpie Trial: a randomised trial comparing magnesium sulphate with placebo for preeclampsia. Outcome for women at 2 years. BJOG. 2007;114(3):300–309.
  • American College of Obstetricians and Gynecologists Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002;98:159–167.
  • Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183(1):S1–SS22.
  • American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–1131.
  • Alexander JM, McIntire DD, Leveno KJ, et al. Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension. Obstet Gynecol. 2006;108(4):826–832.
  • Magee LA, Pels A, Helewa M, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014;36(5):416–441.
  • Nguyen TM, Crowther CA, Wilkinson D, et al. Magnesium sulphate for women at term for neuroprotection of the fetus. Cochrane Database Syst Rev. 2013:CD009395.
  • Ehrenberg HM, Mercer BM. Abbreviated postpartum magnesium sulfate therapy for women with mild preeclampsia: a randomized controlled trial. Obstet Gynecol. 2006;108(4):833–838.
  • Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: evidence from randomized trials. Clin Obstet Gynaecol. 2005;48(2):478–488.
  • Livingston JC, Livingston LW, Ramsey R, et al. Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial. Obstet Gynecol. 2003;101(2):217–220.
  • Witlin AG, Friedman SA, Sibai BM. The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol. 1997;176(3):623–627.
  • Scott JR. Magnesium sulfate for mild preeclampsia. Obstet Gynecol. 2003;101(2):213.
  • Long Q, Oladapo OT, Leathersich S, et al. Clinical practice patterns on the use of magnesium sulphate for treatment of pre-eclampsia and eclampsia: a multi-country survey. BJOG. 2017;124(12):1883–1890.
  • Wataganara T, Titapant V. Management guidelines for preeclampsia. Siriraj Hosp Gaz. 2004;56:604–616.
  • Isler CM, Barrilleaux PS, Rinehart BK, et al. Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapy. Obstet Gynecol. 2003;101(1):66–69.
  • Charoenvidhya D, Manotaya S. Magnesium sulfate maintenance infusion in women with preeclampsia: a randomized comparison between 2 gram per hour and 1 gram per hour. J Med Assoc Thai. 2013;96(4):395–398.
  • Committee on Obstetric. Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. Obstet Gynecol. 2011;118(6):1465–1468.
  • Working Group on clinical management of hypertensive disorders during pregnancy. Administration of magnesium sulfate. 2nd ed. Bangkok, Thailand: Faculty of Medicine Siriraj Hospital; 2014.
  • Centers for Disease Control and Prevention (CDC). [cited 2017 Jan 5]. Available from: https://www.cdc.gov/obesity/adult/defining.html.
  • World Health Organization (WHO). [cited 2017 Jan 5]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/.
  • Wataganara T, Boriboonhirunsarn D, Titapant V, et al. Maternal body mass index at term does not predict the severity of preeclampsia. J Med Assoc Thai. 2008;91(8):1166–1171.
  • Lu JF, Nightingale CH. Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles. Clin Pharmacokinet. 2000;38(4):305–314.
  • Dayicioglu V, Sahinoglu Z, Kol E, et al. The use of standard dose of magnesium sulphate in prophylaxis of eclamptic seizures: do body mass index alterations have any effect on success? Hypertens Pregnancy. 2003;22(3):257–265.
  • Brookfield KF, Su F, Elkomy MH, et al. Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women. Am J Obstet Gynecol. 2016;214(6):737.e1–737.e9.
  • Kokko N, Tannen RI, Kersey R. Magnesium disorders: fluids and electrolytes. 3rd ed. Philadelphia, (PA): W B Saunders Company; 1996.
  • Quamme GA, Dirks JH. Magnesium metabolism. In: Narins RG, editor. Clinical disorders of fluid and electrolyte metabolism. 5th ed. New York, (NY): McGrawHill; 1994. p. 373.
  • Tudela CM, McIntire DD, Alexander JM. Effect of maternal body mass index on serum magnesium levels given for seizure prophylaxis. Obstet Gynecol. 2013;121(2 Pt 1):314–320.
  • Mahajan NN, Thomas A, Soni RN, et al. ‘Padhar regime’ – a low-dose magnesium sulphate treatment for eclampsia. Gynecol Obstet Invest. 2009;67(1):20–24.
  • Shoaib T, Khan S, Javed I, et al. Loading dose of magnesium sulphate versus standard regime for prophylaxis of pre-eclampsia. J Coll Physicians Surg Pak. 2009;19(1):30–33.
  • Okusanya BO, Oladapo OT, Long Q, et al. Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia. BJOG. 2016;123(3):356–366.
  • Sibai BM, Graham JM, McCubbin JH. A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol. 1984;150(6):728–733.
  • Aali S, Khazaeli P, Ghasemi F, et al. Serum magnesium and calcium ions in patients with severe pre-eclampsia/eclampsia undergoing magnesium sulfate therapy. Med Sci Monit. 2007;13(4):CR191–CR194.
  • Handwerker SM, Altura BT, Chi DS, et al. Serum ionized magnesium levels during intravenous MGSO4 therapy of preeclamptic women. Acta Obstet Gynecol Scand. 1995;74(7):517–519.
  • Taber EB, Tan L, Chao CR, et al. Pharmacokinetics of ionized versus total magnesium in subjects with preterm labor and preeclampsia. Am J Obstet Gynecol. 2002;186(5):1017–1021.
  • Duley L, Matar HE, Almerie MQ, et al. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. Cochrane Database Syst Rev. 2010:CD007388.
  • Pritchard JA. The use of the magnesium ion in the management of eclamptogenic toxemias. Surg Gynecol Obstet. 1955;100(2):131–140.
  • Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol. 2004;190(6):1520–1526.
  • Coetzee EJ, Dommisse J, Anthony J. A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol. 1998;105(3):300–303.
  • Belfort MA, Anthony J, Saade GR, et al. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med. 2003;348(4):304–311.
  • Chesley LC, Tepper I. Plasma levels of magnesium attained in magnesium sulfate therapy for preeclampsia and eclampsia. Surg Clin North Am. 1957;37(2):353–367.
  • Eastman NJ, Steptoe PP. The management of pre-eclampsia. Can Med Assoc J. 1945;52(6):562–568.
  • Begum R, Begum A, Johanson R, et al. A low dose (‘Dhaka’) magnesium sulphate regime for eclampsia. Acta Obstet Gynecol Scand. 2001;80(11):998–1002.
  • Aali BS, Khazaeli P, Ghasemi F. Ionized and total magnesium concentration in patients with severe preeclampsia-eclampsia undergoing magnesium sulfate therapy. J Obstet Gynaecol Res. 2007;33(2):138–143.
  • Yoshida M, Matsuda Y, Akizawa Y, et al. Serum ionized magnesium during magnesium sulfate administration for preterm labor and preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2006;128(1–2):125–128.
  • Bain ES, Middleton PF, Crowther CA. Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review. BMC Pregnancy Childbirth. 2013;13:195.
  • Chumpathong S, Sirithanetbhol S, Salakij B, et al. Maternal and neonatal outcomes in women with severe pre-eclampsia undergoing cesarean section: a 10-year retrospective study from a single tertiary care center: anesthetic point of view. J Matern Fetal Neonatal Med. 2016;29(24):4096–4100.
  • Nwanodi OB. Preeclampsia-eclampsia adverse outcomes reduction: the preeclampsia-eclampsia checklist. Healthcare. 2016;4(2):1–15.
  • Centers for Disease Control and Prevention (CDC). [cited 2017 Jan 5]. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/00051880.htm#00003038.
  • Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114(6):1326–1331.
  • Wallach, J. Interpretation of diagnostic tests. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2007.
  • Fischbach FT, Dunning MB III, editors. A Manual of Laboratory and Diagnostic Tests. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.